INS and Hyperinsulinemia: This idea is consistent, for example, with the observation that a dominant-negative mutant version of the IGF1 receptor, but not the concurrent elimination of both the insulin and IGF1 receptors, triggers hyperglycemia and hyperinsulinemia when expressed in the skeletal muscle9.